Larissa Heart Failure Risk Score and Mode of Death in Acute Heart Failure: Insights from REALITY-AHF
暂无分享,去创建一个
Masahiro Yamamoto | F. Triposkiadis | J. Skoularigis | T. Kitai | A. Xanthopoulos | K. Kida | T. Okumura | S. Oishi | G. Giamouzis | Satoshi Suzuki | Y. Matsue | E. Akiyama | Angeliki Bourazana | Yudai Fujimoto
[1] W. Whang,et al. SGLT2 inhibitors reduce sudden cardiac death risk in heart failure: Meta‐analysis of randomized clinical trials , 2023, Journal of cardiovascular electrophysiology.
[2] M. Link,et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2022, Circulation.
[3] G. Sinagra,et al. [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.
[4] A. Konishi,et al. Efficacy of Renin-angiotensin-aldosterone-system inhibitors for heart failure with preserved ejection fraction and left ventricular hypertrophy -from the KUNIUMI Registry Acute Cohort. , 2021, Journal of cardiology.
[5] K. Kinugawa,et al. Interventional heart failure therapy: A new concept fighting against heart failure. , 2021, Journal of cardiology.
[6] Akshay S. Desai,et al. Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial , 2021, Circulation. Heart failure.
[7] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.
[8] V. Roger. Epidemiology of Heart Failure , 2021, Circulation research.
[9] Akshay S. Desai,et al. Dynamic changes in cardiovascular and systemic parameters prior to sudden cardiac death in heart failure with reduced ejection fraction: a PARADIGM‐HF analysis , 2021, European journal of heart failure.
[10] F. Veglia,et al. The MECKI score initiative: Development and state of the art , 2020, European journal of preventive cardiology.
[11] P. Ponikowski,et al. Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2. , 2020, JACC. Heart failure.
[12] Akshay S. Desai,et al. Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis. , 2020, JACC. Heart failure.
[13] J. McMurray,et al. Risk stratification scores for patients with acute heart failure in the Emergency Department: A systematic review , 2020, European heart journal. Acute cardiovascular care.
[14] F. Rutten,et al. Epidemiology of heart failure , 2020, European journal of heart failure.
[15] F. Triposkiadis,et al. Validation of the Larissa Heart Failure Risk Score for risk stratification in acute heart failure. , 2019, International journal of cardiology.
[16] N. Kagiyama,et al. The time-to-treatment concept in acute heart failure: Lessons and implications from REALITY-AHF , 2018, Anatolian journal of cardiology.
[17] W. Tang,et al. Impact of early treatment with intravenous vasodilators and blood pressure reduction in acute heart failure , 2018, Open Heart.
[18] A. Mebazaa,et al. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry. , 2018, JACC. Heart failure.
[19] M. Kattan,et al. Larissa Heart Failure Risk Score: a proposed simple score for risk stratification in chronic heart failure , 2018, European journal of heart failure.
[20] R. Matsukawa,et al. Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure. , 2017, Journal of the American College of Cardiology.
[21] Wen-Chung Yu,et al. Performance of AHEAD Score in an Asian Cohort of Acute Heart Failure With Either Preserved or Reduced Left Ventricular Systolic Function , 2017, Journal of the American Heart Association.
[22] J. Butler,et al. A simple score for early risk stratification in acute heart failure. , 2017, International journal of cardiology.
[23] Hsien-Yen Chang,et al. Relationship between Early Physician Follow-Up and 30-Day Readmission after Acute Myocardial Infarction and Heart Failure , 2017, PloS one.
[24] G. Fonarow,et al. Epidemiology and aetiology of heart failure , 2016, Nature Reviews Cardiology.
[25] Sanjiv J. Shah,et al. Sudden cardiac death in heart failure with preserved ejection fraction: a target for therapy? , 2016, Heart Failure Reviews.
[26] W. Shimizu,et al. New scoring system (APACHE-HF) for predicting adverse outcomes in patients with acute heart failure: evaluation of the APACHE II and Modified APACHE II scoring systems. , 2014, Journal of cardiology.
[27] F. Oliva,et al. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[28] S. Solomon,et al. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM‐Preserved , 2014, European journal of heart failure.
[29] F. Oliva,et al. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score. , 2013, International journal of cardiology.
[30] G. Parati,et al. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. , 2013, International journal of cardiology.
[31] C. O'connor,et al. Association between bilirubin and mode of death in severe systolic heart failure. , 2013, The American journal of cardiology.
[32] V. Hasselblad,et al. Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. , 2010, Journal of the American College of Cardiology.
[33] C. O'connor,et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). , 2008, American heart journal.
[34] D. Mozaffarian,et al. Prediction of Mode of Death in Heart Failure: The Seattle Heart Failure Model , 2007, Circulation.
[35] A. Mebazaa,et al. AHEAD score--Long-term risk classification in acute heart failure. , 2016, International journal of cardiology.